Siglec8 - sialic acid binding Ig-like lectin 8 Gene
Also Known as RGD1563073
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 292846
Summary
Predicted to enable monosaccharide binding activity and sialic acid binding activity. Predicted to act upstream of or within cell adhesion; negative regulation of inflammatory response; and negative regulation of phagocytosis, engulfment. Predicted to be located in external side of plasma membrane. Orthologous to human SIGLEC8 (sialic acid binding Ig like lectin 8). [provided by Alliance of Genome Resources, Apr 2022]
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Inhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P99371 | Lirentelimab | Inducer | 99.91% | Phase 3 |
| HY-P991071 | AK-001 | Inhibitor | / | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS12906 | SIGLEC8 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25064 | Siglec8 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service